首页> 外文OA文献 >Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds
【2h】

Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds

机译:含苯并噻唑支架的仲磺酰胺对碳酸酐酶同工型I,II,IX和XII的抑制作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Carbonic anhydrases (CAs, EC 4.2.1.1) catalyze the fundamental reaction of CO2 hydration in all living organisms, being actively involved in the regulation of a plethora of patho/physiological conditions. A series of benzothiazole-based sulfonamides were synthesized and tested as possible CA inhibitors. Their inhibitory activity was assessed against the cytosolic human isoforms hCA I and hCA II and the transmembrane hCA IX and hCA XII. Several of the investigated derivatives showed interesting inhibition activity and selectivities for inhibiting hCA IX and hCA XII over the off-target ones hCA I and hCA II. Furthermore, computational procedures were used to investigate the binding mode of this class of compounds, within the active site of hCA IX.
机译:碳酸酐酶(CAs,EC 4.2.1.1)催化所有活生物体中CO2水合的基本反应,并积极参与过多病理/生理条件的调节。合成了一系列基于苯并噻唑的磺酰胺,并测试了它们是否可能是CA抑制剂。评估了它们对胞质人同工型hCA I和hCA II以及跨膜hCA IX和hCA XII的抑制活性。一些研究的衍生物显示出比脱靶的hCA I和hCA II更好的抑制hCA IX和hCA XII的抑制活性和选择性。此外,在hCA IX的活性位点内,使用计算程序来研究这类化合物的结合模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号